Physician profile
Muhammad Salim
NPI 1407897259
$8,312.51
in general payments reported to CMS, 2019-2025
30 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,387 · 2020: $1,682 · 2021: $260 · 2022: $690 · 2023: $2,273 · 2024: $1,581 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,486 · Travel and Lodging: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,485.58 |
| Travel and Lodging | $1,807.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,104.36 | 2021-2025 | Corevalve Evolut R, Micra, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $2,683.16 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $393.31 | 2019-2024 | |
| Pfizer INC. | $301.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $198.66 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $185.96 | 2020-2024 | Camzyos, Eliquis |
| Abiomed | $160.41 | 2021-2023 | Impella |
| Philips North America LLC | $142.21 | 2022-2025 | (Ck4) Mcot, Ecc Solutions |
| Boston Scientific Corporation | $138.28 | 2020-2025 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $126.52 | 2021-2023 | Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.84 | 2019-2022 | |
| Novo Nordisk INC | $84.34 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $70.51 | 2020-2025 | Repatha |
| Kestra Medical Technology Services, INC. | $63.96 | 2024 | Assure Wcd |
| Ethicon US, LLC | $58.49 | 2024 | Stratafix, Dermabond |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $57.23 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $51.71 | 2023 | |
| W. L. Gore & Associates, INC. | $50.77 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.77 | 2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $45.84 | 2023 | |
| Cordis US Corp. | $40.22 | 2025 | Precise Pro Rx, Mynx Control Venous |
| Actelion Pharmaceuticals US, INC. | $38.90 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $30.36 | 2024 | Arcalyst |
| Terumo Medical Corporation | $26.19 | 2019-2020 | |
| Esperion Therapeutics, INC. | $25.20 | 2021 | |
| Bard Peripheral Vascular, INC. | $18.67 | 2022 | |
| Stryker Corporation | $17.81 | 2025 | Triever20 |
| Amarin Pharma, INC. | $16.42 | 2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $13.42 | 2022 | |
| Irhythm Technologies, INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Salim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.